Bambusa Therapeutics, Inc. research brief

CIK 2044950 Copy CIK

Generated Nov. 15, 2026, 5:18 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: BOSTON Massachusetts. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Feb. 26, 2025 · D · 0002044950-25-000003 · Source evidence

  Reported offering amount: 88879860 USD. Reported amount sold: 53267941 USD.

• Jan. 8, 2025 · D · 0002044950-25-000002 · Source evidence

  Reported offering amount: 8999974 USD. Reported amount sold: 8999974 USD.

• Jan. 8, 2025 · D · 0002044950-25-000001 · Source evidence

  Reported offering amount: 5099997 USD. Reported amount sold: 5099997 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Bambusa Therapeutics, Inc. research brief,” CIK 2044950, retrieved Nov. 15, 2026, 5:18 a.m.. Cite the specific accessions used. No amounts have been summed.